Autoimmune Cytopenias
Clinical research in autoimmune cytopenias includes warm autoimmune hemolytic anemia (wAIHA), cold agglutinin disease (CAD), and immune thrombocytopenia (ITP), with attention to immune-mediated blood cell destruction and platelet loss.
- wAIHA
- CAD
- ITP
The sponsor’s work in this area is centered on povetacicept and its role in conditions driven by abnormal autoantibody activity and immune dysregulation.
Immunoglobulin A Nephropathy
Research in immunoglobulin A nephropathy focuses on kidney disease marked by proteinuria and progressive loss of renal function, reflecting a strong interest in glomerular disease.
- Proteinuria
- Renal function
- Glomerular disease
These studies examine povetacicept in adults with IgAN, highlighting a therapeutic focus on immune-driven kidney injury.
Immune-Mediated Disease Modulation
The sponsor’s clinical portfolio is concentrated on disorders in which B-cell and antibody-mediated pathways contribute to disease activity, spanning both hematologic and renal settings.
- B-cell pathway modulation
- Antibody-mediated disease
- Immune system regulation
This therapeutic area links autoimmune blood disorders with kidney inflammation through a shared immunologic mechanism.
Inflammatory and Renal Therapeutics
Clinical activity also extends to inflammatory disease and renal therapeutics, with emphasis on conditions where immune activation affects organ function and symptom burden.
- Inflammatory disease
- Renal therapeutics
- Organ-specific immune injury
The research landscape reflects interest in treatment strategies for hematologic autoimmunity and chronic kidney disease associated with immune pathology.
